DOI:
10.1055/s-00000125
Senologie - Zeitschrift für Mammadiagnostik und -therapie
LinksClose Window
References
Turner NC, Telli ML, Rugo HS. et al.
A Phase II Study of Talazoparib after Platinum or Cytotoxic Nonplatinum Regimens in Patients with Advanced Breast Cancer and Germline BRCA1/2 Mutations (ABRAZO).
Clin Cancer Res 2019;
25: 2717-2724
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.